Skip to main content
Nykode Therapeutics AS (OSL:NYKD)
Norway flag Norway · Delayed Price · Currency is NOK
3.030
-0.050 (-1.62%)
Apr 29, 2026, 3:48 PM CET

Nykode Therapeutics AS Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
1,0067889956,9888,28723,372
Upgrade
Market Cap Growth
46.53%-20.81%-85.77%-15.67%-64.54%9.44%
Upgrade
Enterprise Value
424178-2705,3536,04021,724
Upgrade
Last Close Price
3.082.411.9913.9818.3752.72
Upgrade
Forward PE
----4.324.32
Upgrade
PS Ratio
220.25172.489.5651.7393.1674.18
Upgrade
PB Ratio
1.090.850.644.025.3613.67
Upgrade
P/TBV Ratio
1.090.850.644.035.3613.67
Upgrade
P/FCF Ratio
-----9341.31
Upgrade
P/OCF Ratio
-----2296.91
Upgrade
EV/Sales Ratio
92.7938.99-39.6267.9068.94
Upgrade
EV/FCF Ratio
-1.43----8682.61
Upgrade
Debt / Equity Ratio
0.030.030.030.030.040.04
Upgrade
Debt / FCF Ratio
-----25.25
Upgrade
Net Debt / Equity Ratio
-0.63-0.63-0.82-0.92-1.28-1.14
Upgrade
Net Debt / EBITDA Ratio
2.072.072.352.733.8120.70
Upgrade
Net Debt / FCF Ratio
1.961.962.181.598.60-778.98
Upgrade
Asset Turnover
0.000.000.050.060.040.14
Upgrade
Quick Ratio
9.889.8812.787.945.418.12
Upgrade
Current Ratio
9.999.9912.878.045.448.16
Upgrade
Return on Equity (ROE)
-10.75%-10.75%-25.25%-21.42%-24.35%-5.05%
Upgrade
Return on Assets (ROA)
-14.10%-14.10%-16.70%-16.90%-13.64%-2.72%
Upgrade
Return on Invested Capital (ROIC)
-79.39%-98.49%-250.18%---
Upgrade
Return on Capital Employed (ROCE)
-30.50%-30.50%-33.50%-31.00%-29.10%-4.60%
Upgrade
Earnings Yield
-12.27%-15.67%-44.34%-5.10%-5.08%-0.36%
Upgrade
FCF Yield
-29.56%-37.75%-58.58%-14.30%-2.78%0.01%
Upgrade
Dividend Yield
32.47%-50.26%---
Upgrade
Buyback Yield / Dilution
---8.66%-3.58%-1.32%3.31%
Upgrade
Total Shareholder Return
31.90%-41.60%-3.58%-1.32%3.31%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.